跳至主要内容
临床试验/TCTR20180329008
TCTR20180329008招募中1 期

Effectiveness and Safety of Syzygium sp. Gel for Treatment of Acne: A Pilot Study

Medical Life Sciences Institute0 个研究点目标入组 30 人开始时间: 2018年3月29日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 30 Years(—)
性别
All

入选标准

  • Subjects with mild to moderate acne according to FDA's IGA guideline
  • who approved by dermatologist

排除标准

  • 1. Pregnant women (confirmed by test kids).
  • 2. Nursing or breast feeding women.
  • 3. Subjects with renal impairment or abnormal of liver enzyme.
  • 4. Subject with other conditions such as wound, skin face abnormal, blood chemistry abnormal that would interfere with the assessments.
  • 5. Subjects with history of allergy to Syzygium extract, sunscreen or other ingredients of experimental product.
  • 6. Subjects with severe acne according to FDA’s IGA.
  • 7. Subjects with acne requiring laser therapy.
  • 8. Subjects with acne requiring isotretinoin or antibiotics such as
  • doxycycline therapy
  • 9. Subjects with acne requiring topical product within 3 months before starting date of study.
  • 10. Subjects with other dermatological conditions such as eczema,
  • seborrheic dermatitis requiring interfering treatment.

研究者

发起方
Medical Life Sciences Institute

相似试验